Mandate

Vinge advises Lantmännen in connection with its acquisition of the remaining shares in Scandbio

Vinge has advised Lantmännen in connection with its acquisition of the remaining shares in Scandbio AB. Scandbio AB was founded in 2014 when Lantmännen merged its operations with the Finnish company Neova. Both owners have held an equal number of shares in the 50/50 joint venture company since 2014.

Scandbio is Sweden’s largest company in the fixed refined forestry fuel sector with an annual turnover of around MSEK 1 000. The company is headquartered in Jönköping with operations at five sites in Sweden and one in Latvia. Scandbio manufactures, markets and sells wood pellets fuel to Sweden, Denmark and the Baltic States as well as stable pellets for the Swedish market. The company provides both industrial facilities as well as municipal and state-owned operations, local entrepreneurs and individual home owners with 100 per cent renewable energy.

The transaction is subject to the requisite approvals by the competition authorities.

Vinge’s team consisted of Christina Kokko and Elsie Nassar (M&A) together with Marcus Glader, Johan Wahlbom and Jesper Ekman (Merger filing).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025